ACW Appendix 3Y-Dr George Morstyn 05/06/18 download Created with Sketch. 25.22KB Share ACW Becoming a substantial holder 31/05/18 download Created with Sketch. 991.8KB Share ACW Actinogen Medical to present at BIO International 2018 31/05/18 download Created with Sketch. 2.29MB Share ACW Change in substantial holding 31/05/18 download Created with Sketch. 116.16KB Share ACW Ceasing to be a substantial holder 30/05/18 download Created with Sketch. 140KB Share ACW Information Required Under ASX Listing Rule 3.10.5A 28/05/18 download Created with Sketch. 121.62KB Share ACW Cleansing Notice 28/05/18 download Created with Sketch. 98.1KB Share ACW Appendix 3B 28/05/18 download Created with Sketch. 161.98KB Share ACW Actinogen Medical Investor Conference Call 28/05/18 download Created with Sketch. 1.27MB Share ACW $15m Placement Completed-Including US Cornerstone Investor 23/05/18 PRICE SENSITIVE download Created with Sketch. 206.42KB Share ACW XanADu Interim Analysis-Continuation Without Change 23/05/18 PRICE SENSITIVE download Created with Sketch. 191.01KB Share ACW Trading Halt 21/05/18 PRICE SENSITIVE download Created with Sketch. 207.68KB Share ACW Cleansing Notice 14/05/18 download Created with Sketch. 97.76KB Share ACW Appendix 3B-Exercise of Options 14/05/18 download Created with Sketch. 153.13KB Share ACW XanADu Interim Analysis on track for May/June 10/05/18 download Created with Sketch. 122.53KB Share ACW March 2018 Quarterly Report 26/04/18 PRICE SENSITIVE download Created with Sketch. 301.69KB Share ACW Cleansing Notice 18/04/18 download Created with Sketch. 97.73KB Share ACW Appendix 3B-Exercise of Options 18/04/18 download Created with Sketch. 153.13KB Share ACW New Analyst Report on Actinogen Medical 11/04/18 download Created with Sketch. 124.54KB Share ACW Appendix 3B 03/04/18 download Created with Sketch. 155.49KB Share ACW Mid-Way Point Reached in Landmark Alzheimer's Trial - XanADu 21/03/18 PRICE SENSITIVE download Created with Sketch. 158.89KB Share ACW Investor Presentation 19/03/18 download Created with Sketch. 1.87MB Share ACW Invitation to Investor Briefing 07/03/18 download Created with Sketch. 183.28KB Share ACW Appendix 4D & Half-Year Financial Statements 15/02/18 PRICE SENSITIVE download Created with Sketch. 901.9KB Share ACW Strong Recruitment Progress in Alzheimer's Trial 12/02/18 PRICE SENSITIVE download Created with Sketch. 135.46KB Share ACW New Data Supports Cortisol Hypothesis 06/02/18 PRICE SENSITIVE download Created with Sketch. 208.21KB Share ACW December 2017 Quarterly Report 31/01/18 PRICE SENSITIVE download Created with Sketch. 255.99KB Share ACW Change in substantial holding 29/01/18 download Created with Sketch. 1.13MB Share ACW Appendix 3Y-Dr Geoff Brooke 22/01/18 download Created with Sketch. 25.6KB Share ACW Cleansing Notice 22/01/18 download Created with Sketch. 98.31KB Share ACW Appendix 3B 22/01/18 download Created with Sketch. 154.38KB Share ACW Results of Meeting 18/01/18 download Created with Sketch. 185.38KB Share ACW Lapse of Unlisted Options 02/01/18 download Created with Sketch. 93.15KB Share ACW Change of Directors Interest Notice x 3 21/12/17 download Created with Sketch. 100.1KB Share ACW Appendix 3B 21/12/17 download Created with Sketch. 153.19KB Share ACW Notice of General Meeting/Proxy Form 18/12/17 download Created with Sketch. 378.99KB Share ACW Completion of Cancellation of Unvested Loan Shares 14/12/17 download Created with Sketch. 151.1KB Share ACW Change in substantial holding 13/12/17 download Created with Sketch. 128.19KB Share ACW Cleansing Notice 08/12/17 download Created with Sketch. 98.03KB Share ACW Appendix 3B-Placement 08/12/17 download Created with Sketch. 152.65KB Share ACW Letter to Ineligible Shareholders 07/12/17 download Created with Sketch. 101.08KB Share ACW Letter to Optionholders 01/12/17 download Created with Sketch. 97.45KB Share ACW Appendix 3B 01/12/17 download Created with Sketch. 154.29KB Share ACW Prospectus 01/12/17 PRICE SENSITIVE download Created with Sketch. 322.98KB Share ACW Appendix 3X-Dr Morstyn 01/12/17 download Created with Sketch. 64.08KB Share ACW Appendix 3B 01/12/17 download Created with Sketch. 153.23KB Share ACW Amgen Pioneer Dr George Morstyn Joins Actinogen Board 01/12/17 download Created with Sketch. 131.45KB Share ACW Results of Annual General & Special General Meetings 29/11/17 download Created with Sketch. 214.11KB Share ACW Early Efficacy & Safety Data Planned for XanADu Trial 29/11/17 PRICE SENSITIVE download Created with Sketch. 137.06KB Share ACW Placement Fully Funds Completion of XanADu Alzheimer's Trial 29/11/17 PRICE SENSITIVE download Created with Sketch. 144.04KB Share ACW Managing Director's Annual General Meeting Presentation 29/11/17 download Created with Sketch. 1.08MB Share ACW Chairman's Annual General Meeting Address 29/11/17 download Created with Sketch. 149.37KB Share ACW Trading Halt 27/11/17 PRICE SENSITIVE download Created with Sketch. 221.04KB Share ACW Leading Alzheimer's Researchers to Address Shareholders 22/11/17 download Created with Sketch. 137.66KB Share ACW R&D Rebate Received Totalling $1.22 Million 15/11/17 PRICE SENSITIVE download Created with Sketch. 126.71KB Share ACW Amgen Pioneer to Join Actinogen Board 02/11/17 download Created with Sketch. 143.43KB Share ACW Quarterly Update & Appendix 4C 30/10/17 PRICE SENSITIVE download Created with Sketch. 267.24KB Share ACW Annual Report to Shareholders 23/10/17 download Created with Sketch. 1.38MB Share ACW Notice of Special General Meeting & Proxy Form 23/10/17 download Created with Sketch. 298.95KB Share ACW Notice of Annual General Meeting/Proxy Form 23/10/17 download Created with Sketch. 446.14KB Share ACW Actinogen to be showcased at key conferences 17/10/17 download Created with Sketch. 1.08MB Share ACW Investor Newsletter 12/10/17 download Created with Sketch. 122.09KB Share ACW Final Major Market Patent Granted for Xanamem 11/10/17 PRICE SENSITIVE download Created with Sketch. 132.68KB Share ACW Lapse of Unlisted Options 22/09/17 download Created with Sketch. 92.78KB Share ACW First Patient Completes Landmark Alzheimer's Disease Trial 07/09/17 PRICE SENSITIVE download Created with Sketch. 159.41KB Share ACW Appendix 4G 18/08/17 download Created with Sketch. 151.63KB Share ACW Appendix 4E & Financial Statements 18/08/17 PRICE SENSITIVE download Created with Sketch. 1.39MB Share ACW First UK patient treated in ground-breaking clinical trial 16/08/17 PRICE SENSITIVE download Created with Sketch. 167.64KB Share ACW Final Director's Interest Notice 14/08/17 download Created with Sketch. 26.61KB Share ACW Resignation of Director 14/08/17 download Created with Sketch. 122.09KB Share ACW June Quarterly Update 26/07/17 PRICE SENSITIVE download Created with Sketch. 256.59KB Share ACW Actinogen Presenting at Bioshares Biotech 2017 Summit 19/07/17 download Created with Sketch. 1.16MB Share ACW Appendix 3B-Issue of Employee Options 12/07/17 download Created with Sketch. 150.3KB Share ACW Change of Director's Interest Notice 07/07/17 download Created with Sketch. 24.11KB Share ACW Lapse of Unlisted Options 03/07/17 download Created with Sketch. 92.85KB Share ACW First US Patients Treated in Landmark Alzheimer's Trial 22/06/17 PRICE SENSITIVE download Created with Sketch. 141.76KB Share ACW Actinogen Medical Attending BIO 2017 19/06/17 download Created with Sketch. 1.24MB Share ACW First UK Site Goes Live in Global Alzheimer's Clinical Trial 01/06/17 PRICE SENSITIVE download Created with Sketch. 136.04KB Share ACW First Patient Treated in Landmark Alzheimer's Clinical Trial 16/05/17 PRICE SENSITIVE download Created with Sketch. 143.19KB Share ACW Section 708A Notice 09/05/17 download Created with Sketch. 97.98KB Share ACW Appendix 3B-Exercise of Options 09/05/17 download Created with Sketch. 149.66KB Share ACW Becoming a substantial holder 26/04/17 download Created with Sketch. 125.3KB Share ACW Section 708A Notice 26/04/17 download Created with Sketch. 97.46KB Share ACW Appendix 3B-Exercise of Options 26/04/17 download Created with Sketch. 149.6KB Share ACW March Quarterly Update 26/04/17 PRICE SENSITIVE download Created with Sketch. 262.94KB Share ACW Change of Director's Interest Notice 29/03/17 download Created with Sketch. 24.32KB Share ACW Latest Investor Presentation 27/03/17 download Created with Sketch. 1.17MB Share ACW Change of Director's Interest Notice 27/03/17 download Created with Sketch. 23.23KB Share ACW Appendix 3B 27/03/17 download Created with Sketch. 149.96KB Share ACW Quarterly Investor Newsletter 16/03/17 download Created with Sketch. 100.83KB Share ACW TGA Regulatory Approval for Alzheimer's Phase II Trial 08/03/17 PRICE SENSITIVE download Created with Sketch. 114.8KB Share ACW Initial Director's Interest Notice 01/03/17 download Created with Sketch. 64.01KB Share ACW Actinogen Medical Appoints Dr Geoff Brooke as Chairman 01/03/17 download Created with Sketch. 114.89KB Share ACW Actinogen Medical Financial Results 27/02/17 PRICE SENSITIVE download Created with Sketch. 718.2KB Share ACW UK Regulatory Approval for Alzheimer's Clinical Trial-XanADu 10/02/17 PRICE SENSITIVE download Created with Sketch. 134.23KB Share ACW Xanamem Research Published in Prestigious Medical Journal 09/02/17 PRICE SENSITIVE download Created with Sketch. 158.45KB Share ACW Issue of Employee & Advisor Options 06/02/17 download Created with Sketch. 326.83KB Share ACW Appendix 4C - quarterly 23/01/17 PRICE SENSITIVE download Created with Sketch. 48.42KB Share ACW Ceasing to be a substantial holder 09/01/17 download Created with Sketch. 56.07KB Share ACW FDA Approval to Commence Alzheimer's Disease Clinical Trial 03/01/17 PRICE SENSITIVE download Created with Sketch. 116.67KB Share
(20min delay)
